CP and neoplasm: To dive deeper into the therapeutic potential of our optimal CD47p/AZE–paclitaxome-2, we compared it with these two PTX nanoformulations, CP–PTX and PGG–PTX on tumor penetration, MPS avoidance and anticancer efficacy (Extended Data Fig. 6a–c, Supplementary Table 16 and chemical synthesis in ref. 27).